?Omics? technologies emerged relatively recently and evolved rapidly, becoming essential to almost every aspect of cancer research. In view of this, the Genomics & Epigenomics Shared Resource (GESR) is an indispensable Shared Resource for the Georgetown Lombardi Comprehensive Cancer Center (LCCC) and serves investigators on both the DC and NJ campuses. The objective of the GESR is to provide investigators with diverse, state-of-the- art services for genomic and epigenomic studies, such as DNA/RNA quality assessment, mRNA expression profiling, miRNA expression profiling, DNA sequencing, single nucleotide polymorphism (SNP) genotyping, copy number variation (CNV) analysis, DNA methylation analysis and label-free molecular interaction analysis. The GESR uses a variety of platforms for these services, including bioanalyzer, microarray, next-generation sequencing (NGS), real-time polymerase chain reaction (RT-PCR), count-based expression analysis (NanoString) and surface plasmon resonance (SPR). To facilitate these services, the GESR assists users in DNA/RNA isolation, DNA plating and assay preparation and bioinformatics. In fiscal year (FY) 2017, the GESR provided services to 36 LCCC members from all four Research Programs. It supported 85 manuscripts published in peer-reviewed journals in the funding period. Resource Director Habtom W. Ressom, PhD, has experience in designing and developing workflows to ensure reproducible omics experiments. He is responsible for oversight of the GESR overall services, staff, budget, policies and strategic planning and for providing bioinformatics services. Resource Assistant Director Aykut ren, MD, is an expert in SPR technologies and their application for measurement of the concentrations of specific molecules and determination of intermolecular interactions. Director of Operations David S. Goerlitz, MS, has extensive training and experience in genomic and epigenomic technologies and assays. He manages the day- to-day operations of the GESR and assists investigators with assay design and experimental setup.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA051008-26
Application #
9704642
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2019-05-01
Budget End
2020-04-30
Support Year
26
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Georgetown University
Department
Type
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057
Czarnecka, Magdalena; Lu, Congyi; Pons, Jennifer et al. (2018) Neuropeptide Y receptor interactions regulate its mitogenic activity. Neuropeptides :
Gonzalez, Thomas L; Moos, Rebecca K; Gersch, Christina L et al. (2018) Metabolites of n-Butylparaben and iso-Butylparaben Exhibit Estrogenic Properties in MCF-7 and T47D Human Breast Cancer Cell Lines. Toxicol Sci 164:50-59
Singh, Zeba N; Duong, Vu H; Koka, Rima et al. (2018) High-Risk Acute Promyelocytic Leukemia with Unusual T/Myeloid Immunophenotype Successfully Treated with ATRA and Arsenic Trioxide-Based Regimen. J Hematop 11:67-74
Pannkuk, Evan L; Laiakis, Evagelia C; Fornace Jr, Albert J et al. (2018) A Metabolomic Serum Signature from Nonhuman Primates Treated with a Radiation Countermeasure, Gamma-tocotrienol, and Exposed to Ionizing Radiation. Health Phys 115:3-11
da Cruz, Raquel Santana; Carney, Elissa J; Clarke, Johan et al. (2018) Paternal malnutrition programs breast cancer risk and tumor metabolism in offspring. Breast Cancer Res 20:99
Fan, Ping; Tyagi, Amit K; Agboke, Fadeke A et al. (2018) Modulation of nuclear factor-kappa B activation by the endoplasmic reticulum stress sensor PERK to mediate estrogen-induced apoptosis in breast cancer cells. Cell Death Discov 4:15
Dash, Chiranjeev; Taylor, Teletia R; Makambi, Kepher H et al. (2018) Effect of exercise on metabolic syndrome in black women by family history and predicted risk of breast cancer: The FIERCE Study. Cancer 124:3355-3363
Lynce, Filipa; Blackburn, Matthew J; Cai, Ling et al. (2018) Characteristics and outcomes of breast cancer patients enrolled in the National Cancer Institute Cancer Therapy Evaluation Program sponsored phase I clinical trials. Breast Cancer Res Treat 168:35-41
Paffhausen, Emily S; Alowais, Yasir; Chao, Cara W et al. (2018) Discovery of a stem-like multipotent cell fate. Am J Stem Cells 7:25-37
Lee, Shiao-Pieng; Kao, Chen-Yu; Chang, Shun-Cheng et al. (2018) Tissue distribution and subcellular localizations determine in vivo functional relationship among prostasin, matriptase, HAI-1, and HAI-2 in human skin. PLoS One 13:e0192632

Showing the most recent 10 out of 1120 publications